1. Kelompok Studi Stroke Perhimpunan Dokter Spesialis Saraf
Indonesia. Guideline Stroke 2011. Perhimpunan Dokter Spesialis Saraf Indonesia : Jakarta, 2011 : 14-15. 2. Price dan Sylvia A. Patofisiologi Konsep Klinis Proses-proses Penyakit Ed Ke-6. EGC, Jakarta, 2006 : 1106-29. 3. Marlow C, Van Gijn J, dkk. Stroke Practical Management Third Edition. Blackwell Publishing : UK, 2008 : 411-43. 4. Perhimpunan Dokter Spesialis Saraf Indonesia. Panduan Praktik Klinis Neurologi. Jakarta, 2016 : 154-56. 5. Shah QA dan Qureshi AI. Acute Hypertension in Intracerebral Haemorrhage, Pathophysiology and Management. Europan Neurological Disease. Brussel, 2007 : 1-8. 6. Geraldo EA. Intracerebral Hemorrhage - Brain, Spinal Cord, and Nerve Disorders. Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, 2018 : 1-3. 7. Kelompok Studi Stroke Perhimpunan Dokter Spesialis Saraf Indonesia. Guideline Stroke 2011. Perhimpunan Dokter Spesialis Saraf Indonesia : Jakarta, 2011 : 40-83. 8. Hwong WY, Bots ML, Selvarajah S, Kappelle LJ, Aziz ZA, Sidek NM dan Varrtjes I. Use of a Diagnostic Score to Prioritize Computed Tomographic (CT) Imaging for Patients Suspected of Ischemic Stroke Who May Benefit from Thrombolytic Therapy. France, 2016 : 1-10. 9. Direktorat Bina Farmasi Komunitas Dan Klinik Ditjen Bina Kefarmasian Dan Alat Kesehatan Departemen Kesehatan. Pharmaceutical Care Untuk Penyakit Hipertensi. Departemen Kesehatan Ri, 2006. 10. Coffman JD, Eberhardt RT. Peripheral Arterial Disease Diagnosis and Treatment. New Jersey, 2003. 11. Aiyagari V dan Gorelick PB. Hypertension and Stroke Pathophysiology and Management. London, 2011.